Works matching IS 20479158 AND DT 2025 AND VI 14 AND IP 1
Results: 14
Retrotransposon: an insight into neurological disorders from perspectives of neurodevelopment and aging.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-025-00471-y
- By:
- Publication type:
- Article
Extracellular PHF-tau modulates astrocyte mitochondrial dynamics and mediates neuronal connectivity.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-025-00474-9
- By:
- Publication type:
- Article
Improving vulnerable Calbindin1<sup>−</sup> neurons in the ventral hippocampus rescues tau-induced impairment of episodic memory.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-025-00473-w
- By:
- Publication type:
- Article
Chronic subthalamic nucleus deep brain stimulation reduces pathological TrkB aggregates in a Parkinson's disease rat model.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-025-00472-x
- By:
- Publication type:
- Article
Parkinson's disease and glucose metabolism impairment.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-025-00467-8
- By:
- Publication type:
- Article
The C. elegans gba-3 gene encodes a glucocerebrosidase that exacerbates α-synuclein-mediated impairments in deletion mutants.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-024-00463-4
- By:
- Publication type:
- Article
AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-025-00470-z
- By:
- Publication type:
- Article
Refining α-synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophy.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-025-00469-6
- By:
- Publication type:
- Article
Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-025-00465-w
- By:
- Publication type:
- Article
Correction: Inflammasomes in neurodegenerative diseases.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Correction: CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activation.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer's disease and correlates with tau pathology.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-024-00462-5
- By:
- Publication type:
- Article
Peripheral proteinopathy in neurodegenerative diseases.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-024-00461-6
- By:
- Publication type:
- Article
Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington's disease.
- Published in:
- Translational Neurodegeneration, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40035-025-00466-9
- By:
- Publication type:
- Article